Advertisement
U.S. markets closed
Advertisement

Aclaris Therapeutics, Inc. (ACRS)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
0.8782-0.0122 (-1.37%)
At close: 04:00PM EST
0.9000 +0.02 (+2.48%)
After hours: 07:59PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Hammer

Hammer

Previous Close0.8904
Open0.9320
Bid0.8611 x 900
Ask0.8800 x 1200
Day's Range0.8618 - 0.9782
52 Week Range0.5900 - 18.5400
Volume5,064,879
Avg. Volume3,829,600
Market Cap62.208M
Beta (5Y Monthly)0.66
PE Ratio (TTM)N/A
EPS (TTM)-1.6600
Earnings DateFeb 21, 2024 - Feb 26, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est3.86
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for ACRS

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Aclaris Therapeutics, Inc.
    Daily – Vickers Top Buyers & Sellers for 08/29/2023The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Rating
    Fair Value
    Economic Moat
    3 months agoArgus Research
View more